Undecanoate 250

Undecanoate 250 Dragon Pharma — Overview

Undecanoate 250 Dragon Pharma is injectable Testosterone Undecanoate at 250 mg/ml — the longest-ester testosterone preparation available, providing a depot-style release with a half-life of approximately 20–34 days. Where every other testosterone ester demands injections every 2–7 days to maintain stable plasma levels, Undecanoate 250 achieves therapeutic and performance-range testosterone concentrations from a single injection every 2–4 weeks. This makes it the only testosterone ester practically suited to a genuinely low-frequency injection schedule without pharmacokinetic compromise. The pharmacology of testosterone undecanoate is identical to all other testosterone esters: full aromatization to E2, 5α-reduction to DHT, complete androgenic and anabolic activity, and full HPG axis suppression. The ester affects delivery speed, not mechanism. Available at Steroid Warehouse alongside Enantat 250, Cypionat 250, and Propionat 100 for users comparing testosterone options across the full ester length spectrum.

About the Compound: Testosterone Undecanoate Injectable

• The longest testosterone ester — what that means practically — the undecanoate side chain adds 11 carbons to the testosterone molecule, dramatically slowing esterase cleavage and extending the depot release from the injection site; half-life of approximately 20–34 days means a single 500 mg injection maintains supraphysiologic testosterone levels for 3–4 weeks before a meaningful decline; this is the pharmacokinetic basis for once-every-2-4-week dosing, not a clinical approximation
• Identical pharmacology to all testosterone esters once cleaved — after esterase cleavage at the injection depot, the circulating molecule is free testosterone; aromatization to E2 via CYP19A1, 5α-reduction to DHT via 5AR, AR binding, HPG suppression via hypothalamic feedback, and all anabolic and androgenic effects are identical to Enantat 250, Cypionat 250, or Propionat 100; the ester choice changes timing and injection frequency, not the active hormone
• Depot vehicle and injection volume — injectable testosterone undecanoate is formulated in castor oil, which slows depot absorption further beyond what the ester half-life alone would produce; injection volumes are typically 1–2 ml (250–500 mg); because of the castor oil vehicle, slow, deep intramuscular injection is required to minimize injection site discomfort and reduce the risk of a coughing episode associated with oil-based injectables
• Slow steady-state onset requires a loading strategy — at every-3-week injections, full pharmacokinetic steady state requires 3–4 injection intervals (9–12 weeks); clinical protocols address this with a loading-dose injection at week 0 and week 6 followed by every-10-14-week maintenance; bodybuilding blast protocols compress this by using every-2-week injections for the first 6 weeks, then spacing to every-3-4 weeks; without a loading strategy, week 1–4 testosterone levels will be subtherapeutic in any meaningful performance context

What Undecanoate 250 Does

• Full testosterone anabolic and androgenic activity with a flat release curve — once steady state is established after the loading phase, Undecanoate 250 maintains supraphysiologic testosterone levels with minimal peak-to-trough variation compared to weekly-injection esters; the absence of sharp pharmacokinetic peaks means more consistent E2 and DHT levels, more predictable AI dosing, and a more stable hormonal environment across the cycle compared to twice-weekly or EOD protocols
• Lean mass accrual, strength, and body recomposition — the anabolic effects are those of supraphysiologic testosterone regardless of ester: increased nitrogen retention, enhanced protein synthesis, IGF-1 stimulation, AR-mediated muscle fiber growth, and EPO-driven erythropoiesis; the flat plasma curve of undecanoate does not produce the pronounced strength spikes in the first week that short-ester protocols create, but the sustained stimulus across 2–4 weeks per injection interval produces equivalent cumulative mass and strength gains over a full cycle
• TRT-compatible blast-and-cruise pharmacokinetics — because Undecanoate 250's injection interval mirrors clinical TRT protocols (Nebido: 1000 mg every 10–14 weeks), it is the most practical testosterone ester for users running a long-term blast-and-cruise structure; cruising on 250 mg every 4 weeks (approximately 62.5 mg/week average) maintains testosterone at the high-physiologic range without requiring twice-weekly injections, while a blast phase uses 500 mg every 2–3 weeks
• Erythropoiesis and hematocrit accumulation over long cycles — the sustained testosterone stimulus from the undecanoate ester drives EPO-mediated RBC production without the injection-day peaks seen with shorter esters; this makes hematocrit elevation a slower but persistent process; borderline hematocrit at week 8 will reliably worsen by week 16 in the absence of active management

Who It's For

• Key differentiator from all other testosterone esters — Undecanoate 250 is defined by one thing: the fewest injections per cycle of any testosterone ester; it does not produce faster onset, higher peak anabolic stimulus, or superior mass gains versus Enantat 250 at equivalent weekly doses; the sole practical advantage is injection frequency — users who want a credible testosterone base with 1–2 injections per month instead of 2 per week have no injectable alternative in the Dragon Pharma testosterone lineup
• Best scenario — experienced injectable users running long cycles (14–20+ weeks) or blast-and-cruise protocols who want to minimize injection burden; users whose lifestyle, travel schedule, or injection site recovery limits access to twice-weekly administrations; users already familiar with AI management and bloodwork monitoring who want to optimize injection convenience without switching to a fundamentally different hormone
• Choose something else instead — first-time injectable users should start with Enantat 250 Dragon Pharma (twice-weekly, predictable, well-studied) where any side effect can be addressed by missing the next injection within days, not weeks; users wanting rapid cycle onset should use Enantat 250 or Cypionat 250 Dragon Pharma; users needing fast clearance for PCT timing should use Propionat 100 Dragon Pharma

Undecanoate 250 vs Alternatives

Combinations

Side Effects & Management

Bloodwork Monitoring

Post-Cycle Recovery

Undecanoate 250's half-life of 20–34 days means substantial testosterone plasma persists for 6–8 weeks after the last injection. Starting SERM while active testosterone remains in circulation counteracts PCT recovery. HCG begins during the clearance window; SERM begins only after clearance is near-complete.

For full PCT timing and dosing context, see the PCT guide.

Practical Summary

Undecanoate 250 Dragon Pharma occupies a specific and well-defined role in the injectable testosterone lineup: the only ester that supports a genuine 2–4 week injection schedule without pharmacokinetic compromise. For experienced users running long blast cycles or blast-and-cruise protocols where injection burden is a limiting factor, steroidwarehouse.com's Undecanoate 250 provides full testosterone activity — identical anabolic output, identical side effect profile, identical AI and PCT requirements — with significantly fewer injections than any alternative ester in the Dragon Pharma range.

References